---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-25-000029"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:14:22.097536+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# iBio updates corporate presentation highlighting obesity and cardiometabolic disease antibodies

## Summary
- Filed updated corporate presentation dated June 2025 for investor meetings.
- Presentation focuses on breakthrough antibodies for obesity and cardiometabolic diseases.
- No financial or pipeline specifics disclosed in the filing or attached exhibit.

## SEC filing metadata
- accession: 0001420720-25-000029
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/0001420720-25-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/ibio-20250624x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-25-000029
- JSON: https://secwatch.observer/filing/0001420720-25-000029.json
- Plain text: https://secwatch.observer/filing/0001420720-25-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.